BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 24, 2007
View Archived Issues
Discovery receives FDA guidance on path to Surfaxin approval
Read More
Progress in phase II trial of AL-208 for MCI in CABG
Read More
CLS-001 begins phase II study in rosacea
Read More
Fast track designation for SQ-109 for treatment of pulmonary TB
Read More
IND accepted for iCo-007 in diabetic macular edema
Read More
FDA accepts sNDA for Doxil + Velcade in relapsed/refractory multiple myeloma
Read More
Geron licenses MaxCyte technology for use in cancer vaccines
Read More
CollaRx gentamicin cleared to begin phase II study for infected diabetic foot ulcers
Read More
Anticancer drug WBI-2100 stimulates immune system in preclinical studies
Read More
Shire licenses North American rights to SPD-754 to Avexa
Read More
RhuDex studied for rheumatoid arthritis in new phase IIa study
Read More
NDA resubmission for indiplon capsules planned for Q2 2007
Read More
Samaritan inlicenses rights to Infasurf
Read More
Enrollment begins in phase III ophthalmic trials of difluprednate
Read More
Analysis bolsters SAINT I findings of NXY-059 in ischemic stroke
Read More
Enzyme replacement therapy to be evaluated in metachromatic leukodystrophy/News in context
Read More
rHuPH20 increases bioavailability of large protein molecule therapeutic
Read More
Novel agents for thrombotic disorders disclosed in recent Pfizer and Bristol-Myers Squibb patents
Read More
Recent AstraZeneca patent imparts novel anxiolytic agents
Read More
E.U. approval for Lucentis in wet AMD
Read More
Pharmion files MAA for Thalidomide Pharmion for multiple myeloma
Read More
Recent patents announce novel antidiabetic agents
Read More
Pfizer recaps highlights of 2006
Read More
DCA inhibits cancer growth by normalizing mitochondrial function and promoting apoptosis
Read More
Medicure reviews Q2 highlights
Read More